AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|
20.3 C
New York
Tuesday, September 15, 2026

Tag: newswire

Solis partners with DIDWW to facilitate expansion in Europe through advanced VoIP services

DUBLIN, July 01, 2025 (GLOBE NEWSWIRE) -- Solis (Ginlong Technologies), the world’s third largest PV inverter manufacturer, has teamed up with DIDWW, a leading telecom provider specializing in virtual phone numbers and two-way SIP trunking services for businesses all over the world. This initiative will equip Solis with a reliable and highly flexible VoIP communications solution, strengthening its expansion across Europe while leveraging seamless connectivity in global markets.

Inmarsat NexusWave Exceeds 1,000 Vessel Orders Amid Growing Demand for High-Speed Connectivity

Inmarsat Maritime's NexusWave service has exceeded 1,000 vessel orders amid growing demand for high-speed connectivity

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals

Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals

SOUEAST Officially Enters Morocco, Launching New Journey in North African Market

CASABLANCA, Morocco, July 01, 2025 (GLOBE NEWSWIRE) -- SOUEAST announced its official entry into the Morocco market, marking the launch of its North African strategy and a major breakthrough in its global expansion. It will offer EASE urban mobility experiences to Moroccan and even North African consumers.

Gate Surpasses 30 Million Global Users, Accelerating Its Rise as the Next-Generation Crypto Exchange

PANAMA CITY, July 01, 2025 (GLOBE NEWSWIRE) -- Gate, a globally leading cryptocurrency trading platform, has officially surpassed 30 million registered users, marking a new milestone in its global expansion. This remarkable achievement underscores the platform’s growing influence across international markets and highlights the progress Gate has made in strategic transformation, brand upgrade, and ecosystem development.

Indonesia’s Top Employers Forge the Future of Work: HR Asia Honors 80 Companies in Talent Innovation

JAKARTA, Indonesia, July 01, 2025 (GLOBE NEWSWIRE) -- HR Asia Best Companies to Work for in Asia, owned by Business Media International, proudly honours 80 organizations that exemplify excellence in human capital strategy and workplace culture. This year’s ceremony arrives as Indonesian companies navigate critical challenges in talent retention, multigenerational workforce integration, and shifting employee expectations.

ProLogium’s Next-Generation Lithium Ceramic Battery Shipments Surpass 2.4 Million Units

A New Milestone in the commercialization of Green Energy Technologies
A New Milestone in the commercialization of Green Energy Technologies

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss

Rincell-1 addresses a multi $Bn global market opportunity where no disease modifying treatments currently exist
Rincell-1 addresses a multi $Bn global market opportunity  where no disease modifying treatments currently exist

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application

EINDHOVEN, the Netherlands, July 01, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announced the submission of two major regulatory applications for its ARC-EX System. The Company has submitted a 510(k) application to the US Food and Drug Administration (FDA) seeking clearance to expand its indication for home use. In parallel, ONWARD has filed an application with the notified body for CE Mark certification in accordance with the European Union Medical Device Regulation (MDR) to enable commercialization of the ARC-EX System in the EU. Completed in June, these submissions represent significant milestones as the Company advances its mission to bring breakthrough therapies to people with SCI around the world.

From Gaza to Africa: Equalall widens its Urgent Global Fundraising Drive to Support Crisis-Affected Communities in Africa

Global non-profit Equalall has so far been involved in fundraising for and mobilizing life-saving aid for victims of war, displacement, and natural disasters in Gaza, Syria, Sudan
Global non-profit Equalall has so far been involved in fundraising for and mobilizing life-saving aid for victims of war, displacement, and natural disasters in Gaza, Syria, Sudan

ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility

LAUSANNE, Switzerland and COPENHAGEN, Denmark, July 01, 2025 (GLOBE NEWSWIRE) -- ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced that the first participant has been included in the company’s Phase 2 clinical trial of its lead candidate RPN-001 (leflutrozole), an orally administered aromatase inhibitor in development for the treatment of male infertility (https://clinicaltrials.gov/study/NCT06993155?term=Leflutrozole&rank=1).

Bitget Launchpool, 460만 토큰 보상으로 프래그메트릭(FRAG) 상장 예정

빅토리아, 세이셸, July 01, 2025 (GLOBE NEWSWIRE) -- 암호화폐 거래소이자 웹3.0 기업인 Bitget이 프래그매틱(Fragmetic, FRAG)을 이노베이션, LSD, 솔라나 생태계 존에 상장하여 현물 거래할 예정이라고 발표했다. FRAG/USDT 쌍은 2025년 7월 1일 8시 30분(UTC)에 시작되며, 출금은 2025년 7월 2일 9시 30분(UTC)에 가능하다. 현물 거래와 더불어 Bitget은 런치풀 (Launchpool) 보상 캠페인을 시작한다. 자격을 갖춘 사용자는 BGB와 FRAG를 락업하여 4,200,000 FRAG의 지분 획득이 가능하다. 런치풀 캠페인은 2025년 7월 1일 8:30부터 2025년 7월 4일 8:30(UTC)까지 진행될 예정이다. BGB 캠페인 풀에는 3,800,000 FRAG가, FRAG 캠페인 풀에는 400,000 FRAG가 걸려 있는 상황이다.

Commencement of Chief Executive Officer

PERTH, Australia, July 01, 2025 (GLOBE NEWSWIRE) -- Canyon Resources Limited (ASX: CAY) (‘Canyon’ or the ‘Company’) is pleased to announce that Mr Peter Secker has officially commenced his role as Chief Executive Officer (CEO), effective 1 July 2025.

Product of the Year Malaysia Shares Highlights from Malaysia 2025 Awards Coverage

In a time when credibility is more important than ever, Voted Product of the Year stands apart by putting the power in the hands of consumers.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNewswire